↓ Skip to main content

Cochrane Database of Systematic Reviews

Clozapine versus typical neuroleptic medication for schizophrenia

Overview of attention for article published in Cochrane database of systematic reviews, January 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
twitter
7 tweeters
weibo
1 weibo user
wikipedia
5 Wikipedia pages

Citations

dimensions_citation
180 Dimensions

Readers on

mendeley
481 Mendeley
Title
Clozapine versus typical neuroleptic medication for schizophrenia
Published in
Cochrane database of systematic reviews, January 2009
DOI 10.1002/14651858.cd000059.pub2
Pubmed ID
Authors

Adib Essali, Nahla Al-Haj Haasan, Chunbo Li, John Rathbone

Abstract

Long-term drug treatment of schizophrenia with typical antipsychotics has limitations: 25 to 33% of patients have illnesses that are treatment-resistant. Clozapine is an antipsychotic drug, which is claimed to have superior efficacy and to cause fewer motor adverse effects than typical drugs for people with treatment-resistant illnesses. Clozapine carries a significant risk of serious blood disorders, which necessitates mandatory weekly blood monitoring at least during the first months of treatment.

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 481 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
Germany 2 <1%
Spain 2 <1%
Canada 2 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Australia 1 <1%
Chile 1 <1%
Portugal 1 <1%
Other 0 0%
Unknown 468 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 79 16%
Student > Master 76 16%
Student > Ph. D. Student 52 11%
Student > Bachelor 51 11%
Student > Doctoral Student 37 8%
Other 114 24%
Unknown 72 15%
Readers by discipline Count As %
Medicine and Dentistry 178 37%
Psychology 73 15%
Nursing and Health Professions 35 7%
Pharmacology, Toxicology and Pharmaceutical Science 22 5%
Social Sciences 18 4%
Other 64 13%
Unknown 91 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 September 2021.
All research outputs
#1,149,896
of 19,140,651 outputs
Outputs from Cochrane database of systematic reviews
#2,853
of 11,934 outputs
Outputs of similar age
#5,628
of 103,691 outputs
Outputs of similar age from Cochrane database of systematic reviews
#13
of 107 outputs
Altmetric has tracked 19,140,651 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,934 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 27.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 103,691 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 107 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.